{"canonical":"https://abierto.us/opportunities/fda7162026","key":"FDA7162026","url":"https://abierto.us/opportunities/fda7162026","title":"Intent to Sole Source to Johnson, Mirmiran & Thompson Inc.","solicitation_number":"FDA_7162026","notice_type":"s","open":false,"response_deadline":"2026-07-30T15:00:00Z","first_posted":"2026-07-17","last_posted":"2026-07-17","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"FOOD AND DRUG ADMINISTRATION","office":"FDA NEGOTIATED CONTRACTS BRANCH","naics":"541620","psc":"B537","set_aside":null,"place_state":"MD","winner":null,"award_amount":null,"publications":[{"notice_id":"b182ee23a9384f409b0dbc6badb49480","title":"Intent to Sole Source to Johnson, Mirmiran & Thompson Inc.","solicitation_number":"FDA_7162026","notice_type":"s","base_type":"s","posted":"2026-07-17","posted_at":null,"due_at":"2026-07-30T15:00:00Z","due_date":"2026-07-30","cancelled":null,"archived":null,"archive_date":"2026-08-14","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/b182ee23a9384f409b0dbc6badb49480/view","enriched":false,"history":[]}],"latest_notice_id":"b182ee23a9384f409b0dbc6badb49480","first_type":"s","notices":[{"dates":{"posted":"2026-07-17","response_deadline":{"raw":"2026-07-30T11:00:00-04:00","utc":"2026-07-30T15:00:00Z","date":"2026-07-30","time":"11:00:00","utc_offset_seconds":-14400}},"links":{"sam":"https://sam.gov/workspace/contract/opp/b182ee23a9384f409b0dbc6badb49480/view"},"naics":{"codes":["541620"],"primary":"541620"},"title":"Intent to Sole Source to Johnson, Mirmiran & Thompson Inc.","agency":{"office":{"code":"752401","name":"FDA NEGOTIATED CONTRACTS BRANCH"},"subtier":{"code":"7524","name":"FOOD AND DRUG ADMINISTRATION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20857","city":"ROCKVILLE","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2026-08-14","archive_type":"auto15"},"contacts":[{"name":"Howard Yablon","role":"primary","email":"howard.yablon@fda.hhs.gov"},{"name":"Ian Weiss","role":"secondary","email":"ian.weiss@fda.hhs.gov"}],"base_type":{"code":"s","label":"Special Notice"},"notice_id":"b182ee23a9384f409b0dbc6badb49480","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2026_archived_opportunities.csv","etag":"\"d9374b90a938e9923d910594731b7b57-106\"","fetched_at":"2026-09-16T00:55:27.040971Z","row_sha256":"bb4ab51d188c4c739b56a475fce9e2c7c5e82f1f606707e1350390479ae8a4fc","last_modified":"2026-09-13T14:50:39Z"},"updated_at":"2026-09-16T00:55:27.040971Z","first_seen_at":"2026-09-16T00:55:27.040971Z"},"description":{"text":"The objective of this contract is to prepare and document an appropriate level of environmental review under NEPA, applicable regulations and guidance, prior to issuing the final Sunscreen OTC Monograph Order regarding ZnO and TiO2. Specifically, the intent is to finalize the EA on ZnO and TiO2 including appendices or, if necessary, to exercise an option under this contract to prepare and finalize an EIS for these active ingredients.","origin":"extract"},"notice_type":{"code":"s","label":"Special Notice"},"schema_version":1,"solicitation_number":"FDA_7162026","place_of_performance":{"zip":"21030","city":{"name":"Hunt Valley"},"state":{"code":"MD"},"country":{"code":"USA"}},"product_service_code":"B537"}],"due_at":"2026-07-30T15:00:00Z","due_date":"2026-07-30","closes_at":"2026-07-30T15:00:00Z","awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7524","sub_name":"FOOD AND DRUG ADMINISTRATION","office_key":"o-752401","office_name":"FDA NEGOTIATED CONTRACTS BRANCH","state":"MD","country":"USA","winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z","principal_notice_id":"b182ee23a9384f409b0dbc6badb49480","description":{"text":"The objective of this contract is to prepare and document an appropriate level of environmental review under NEPA, applicable regulations and guidance, prior to issuing the final Sunscreen OTC Monograph Order regarding ZnO and TiO2. Specifically, the intent is to finalize the EA on ZnO and TiO2 including appendices or, if necessary, to exercise an option under this contract to prepare and finalize an EIS for these active ingredients.","html":null,"origin":"extract"},"contacts":[{"name":"Howard Yablon","role":"primary","email":"howard.yablon@fda.hhs.gov"},{"name":"Ian Weiss","role":"secondary","email":"ian.weiss@fda.hhs.gov"}],"place_of_performance":{"zip":"21030","city":{"name":"Hunt Valley"},"state":{"code":"MD"},"country":{"code":"USA"}},"office_address":{"zip":"20857","city":"ROCKVILLE","state":"MD","country":"USA"},"naics_codes":["541620"],"award":null,"attachments":[],"awards":[],"related":[]}